Skip to content

Other financials

Income statement

See full
Revenue$63.7M+2.6%
Gross profit$31.2M-0.5%
Operating income-$664.0K+85.5%
Net income$3.6M+317%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Cash & equivalents$26.9M-1.4%
Total debt$78.7M-53.1%
Total equity$186.2M+16.5%
Total assets$427.7M-1.3%

Cash flow

See full
Operating cash flow$14.0M+10.2%
CapEx$417.0K-44.9%
Free cash flow$13.5M+13.7%

Valuation

See full
Market cap$542.27M+3.7%
Enterprise value$594.05M-10.4%
P/S2.2×0.0×

Profitability

See full
Gross margin56.8%
Operating margin2.3%
Net margin1.5%+0.8pp
FCF margin15.9%-1.8pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.4×-0.6×
Current ratio1.7×+1.1×

Where this comes from

Reported directly by Mesa Laboratories in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic.

The official record: Mesa Laboratories’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Mesa Laboratories's net income?
Mesa Laboratories (MLAB) reported net income of $3.63M in Q4 2025.
How has Mesa Laboratories's net income changed year-over-year?
Mesa Laboratories's net income increased by 316.6% year-over-year, from -$1.68M to $3.63M.
What is the long-term trend for Mesa Laboratories's net income?
Over 2 years (2023 to 2025), Mesa Laboratories's net income has grown at a 45.7% compound annual growth rate (CAGR), from $930K to -$1.97M.